P-50 Prognostic factors in patients receiving trifluridine/tipiracil for refractory metastatic colorectal cancer in the real-life setting: The ROS study
| Autor: | García-Alfonso, P., Reina Zoilo, J., Mata Velasco, E., Llanos, M., Illán Varella, A., Safont Aguilera, M., Delgado Ureña, M., Castañón, C., Pimentel, P., Alonso Orduña, V., Mendez, J., Rivera Herrero, F., Siso, I., Rodriguez-Pascual, J., Grávalos Castro, C., Afonso, R., Fernandez Rañada, I., Grández, R., Moreno, M., López Muñoz, A., García-Paredes, B., Aranda, E. |
|---|---|
| Zdroj: | In Annals of Oncology July 2021 32 Supplement 3:S113-S113 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|